건강보험 급여 한약제제와 양방 처방의약품의 병용투여 현황
Concurrent Use of Korean Herbal Medicines and Western Chemical Medicines: Evidence from HIRA-NPS
2
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Objective : The purpose of this study is to analyze Korean patients’ characteristics, who were concurrently treated with both Korean herbal medicines and Western chemical medicines using nation-wide database. Method : Using the patients sample data (HIRA-NPS 2018) provided by Health Insurance Review and Assessment Service, a group of patients who co-administered Korean herbal and Western medicines was selected, and their basic characteristics, diagnosis, and prescribed chemical medicines were analyzed. Results : Out of the 1,481,921 sample population, 17,629 patients (1.2%) were selected as a concurrent medication group. Compared to the whole sample, the concurrent medication group was composed of more women (65.8% vs. 51.1%), the more elderly people (65 or older years old) (44.5% vs. 14.6%), and the higher prevalence of chronic diseases (49.1% vs. 22.2%). The most frequent diagnosis treated with Western medicines was mental and behavioral disorders, musculoskeletal and circulatory disorders. Frequently used drugs among concurrent medication group were anti-anxiety drugs, gastric ulcer treatment drugs, and senile diseases treatment drugs. Conclusion : The evidence reported in this study is expected to provide herb-drug interaction researchers with important reference to set the priorities of research topics in the future.
Abstract
Objective : The purpose of this study is to analyze Korean patients’ characteristics, who were concurrently treated with both Korean herbal medicines and Western chemical medicines using nation-wide database. Method : Using the patients sample data (HIRA-NPS 2018) provided by Health Insurance Review and Assessment Service, a group of patients who co-administered Korean herbal and Western medicines was selected, and their basic characteristics, diagnosis, and prescribed chemical medicines were analyzed. Results : Out of the 1,481,921 sample population, 17,629 patients (1.2%) were selected as a concurrent medication group. Compared to the whole sample, the concurrent medication group was composed of more women (65.8% vs. 51.1%), the more elderly people (65 or older years old) (44.5% vs. 14.6%), and the higher prevalence of chronic diseases (49.1% vs. 22.2%). The most frequent diagnosis treated with Western medicines was mental and behavioral disorders, musculoskeletal and circulatory disorders. Frequently used drugs among concurrent medication group were anti-anxiety drugs, gastric ulcer treatment drugs, and senile diseases treatment drugs. Conclusion : The evidence reported in this study is expected to provide herb-drug interaction researchers with important reference to set the priorities of research topics in the future.
참고문헌 (17)
- Usage and Consumption of Korean Medicine Report in 2017, "Ministry of Health and Welfare", Ministry of Health and Welfare, ~ (2017)
- Moschik E, "Usage and attitudes of physicians in Japan concerning traditional Japanese medicine (kampo medicine): a descriptive evaluation of a representative questionnaire-based survey", Evid Based Complement Alternat Med, pp.139818~ (2012)
- 김동현, "골관절염 환자의 한약 양약 투여 현황 및 안전성 연구", 대한한방내과학회지, 39(2), pp.97~106 (2018), 대한한방내과학회
- 이인, "와파린과 상호작용하는 한약재에 대한 고찰", 대한한방내과학회지, 33(2), pp.160~171 (2012), 대한한방내과학회
- 김춘배, "암 환자의 한약, 양약 병용 투여", 대한한의학회지, 28(2), pp.205~212 (2007), 대한한의학회
- 이은형, "한약과 양약의 병용 치료를 통한 약인성 간손상 치험례 1례", 동의생리병리학회지, 21(1), pp.285~290 (2007), 한의병리학회
- 이상욱, "뇌졸중환자에서 한약과 양약의 병용투여가 간장 및 신장에 미치는 영향", 대한한방내과학회지, 24(1), pp.68~74 (2003), 대한한방내과학회
- 박종구, "뇌졸증환자의 한약, 양약 복합 투여에 관한 단면연구", 대한한의학회지, 27(1), pp.1~10 (2006), 대한한의학회
- 오문수, "한⋅양방 병원 외래환자의 한⋅양약 동시복용 경험 실태조사", 대한한의학 방제학회지, 18(2), pp.135~158 (2010), 대한한의학방제학회
- 김미연, "소아 1형 당뇨의 한약과 양약 병용 치료에 대한 체계적 문헌 고찰 및 메타분석", 대한한방소아과학회지, 33(3), pp.15~29 (2019), 대한한방소아과학회[DOI]
- 박수진, "국내 한약-양약 상호작용 연구논문 분석을 통한 상호작용 정보 현황파악 및 제공방안에 대한 연구", 동의생리병리학회지, 24(4), pp.543~552 (2010), 한의병리학회
- "Ministry of Health and Welfare Notice No. 2020-338: The reimbursement and limit price list of oriental medicine" (2020)[URL]
- "Reimbursed Drug Statistics. Wonju: Health Insurance Review & Assessment Service" (2020)[URL]
- Wolff JL, "Prevalence, expenditures, and complications of multiple chronic conditions in the elderly", Arch Intern Med, 162, pp.2269~2276 (2002)[DOI]
- A Survey about potentially harmful drug-drug interactions in older people, "SJ Yoon", Health Insurance Review & Assessment Service, ~ (2017)
- 조여향, "Drug Utilization Review 시행 전후 3차 의료기관에서의 노인주의약품 외래처방 현황 분석", 한국임상약학회지, 29(1), pp.25~32 (2019), 한국임상약학회[DOI]
- 김석주, "불면장애 진단과 치료의 최신 지견", 신경정신의학, 59(1), pp.2~12 (2020), 대한신경정신의학회[DOI]